Pharma & Biotech

The publicly traded journey of G1 Therapeutics has reached its conclusion. The biotechnology firm ceased trading on the NASDAQ effective...

The future of CureVac as an independent entity now rests in shareholders' hands as a decisive vote approaches. Investors will...

Intellia Therapeutics, a prominent player in the gene-editing sector, is confronting a severe crisis after a fatality occurred in a...

A significant vote of confidence has been placed in Redcare Pharmacy, not through words, but through a substantial financial commitment....

Investors in Bionxt Solutions find themselves confronting a puzzling market scenario. Despite receiving significant regulatory approvals for a promising multiple...

Danish pharmaceutical leader Novo Nordisk is confronting a severe market downturn as major investors rapidly divest their holdings. The company's...

Redcare Pharmacy is making a strategic leadership move by appointing an Amazon finance veteran as its new Chief Financial Officer....

The Danish pharmaceutical firm Novo Nordisk, which held the title of Europe's most valuable corporation just a year ago, is...

Despite being mired in a significant downturn, Redcare Pharmacy is attracting attention from company insiders. A notable transaction has occurred...

UnitedHealth Group has made a strategic addition to its board of directors, bringing in former U.S. Food and Drug Administration...